Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × erdafitinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Radiotherapy 192 Cisplatin 166 Cyclophosphamide 147 Doxorubicin 120 Paclitaxel 115 Vincristine 107 Filgrastim 105 Etoposide 90 Carboplatin 90 Gemcitabine 74 Methotrexate 73 Docetaxel 70 Fluorouracil 68 Cytarabine 67 Gene Expression Profiling 66 Prednisone 62 Dexamethasone 62 Granulocyte Colony-Stimulating Factor 58 Leucovorin 54 Polymerase Chain Reaction 42 Immunohistochemistry 42 Microarray Analysis 38 Ifosfamide 35 Irinotecan 34 Daunorubicin 33 Temozolomide 32 Amplified Fragment Length Polymorphism Analysis 30 Cetuximab 29 Capecitabine 29 Flow Cytometry 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡